Synthesis of a Systematic 64-Membered Heparan Sulfate Tetrasaccharide Library

被引:19
作者
Baryal, Kedar N. [1 ]
Ramadan, Sherif [1 ,2 ]
Su, Guowei [3 ]
Huo, Changxin [1 ]
Zhao, Yuetao [1 ,4 ]
Liu, Jian [5 ]
Hsieh-Wilson, Linda C. [6 ]
Huang, Xuefei [1 ,7 ,8 ]
机构
[1] Michigan State Univ, Dept Chem, 578 S Shaw Lane, E Lansing, MI 48824 USA
[2] Benha Univ, Fac Sci, Chem Dept, Banha 13518, Qaliobiya, Egypt
[3] Glycan Therapeut, 617 Hutton St, Raleigh, NC 27606 USA
[4] Cent South Univ, Sch Life Sci, Changsha 410013, Hunan, Peoples R China
[5] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[6] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA
[7] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA
[8] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA
关键词
biological activity; carbohydrates; heparan sulfate; library synthesis; oligosaccharides; PLATELET FACTOR-IV; BINDING; PROTEOGLYCANS; REQUIREMENTS;
D O I
10.1002/anie.202211985
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Heparan sulfate (HS) has multifaceted biological activities. To date, no libraries of HS oligosaccharides bearing systematically varied sulfation structures are available owing to the challenges in synthesizing a large number of HS oligosaccharides. To overcome the obstacles and expedite the synthesis, a divergent approach was designed, where 64 HS tetrasaccharides covering all possible structures of 2-O-, 6-O- and N-sulfation with the glucosamine-glucuronic acid-glucosamine-iduronic acid backbone were successfully produced from a single strategically protected tetrasaccharide intermediate. This extensive library helped identify the structural requirements for HS sequences to have strong fibroblast growth factor-2 binding but a weak affinity for platelet factor-4. Such a strategy to separate out these two interactions could lead to new HS-based potential therapeutics without the dangerous adverse effect of heparin-induced thrombocytopenia.
引用
收藏
页数:12
相关论文
共 53 条
[1]  
ANGIBEAUD P, 1985, SYNTHESIS-STUTTGART, P1123
[2]   Heparin-Induced Thrombocytopenia: A Focus on Thrombosis [J].
Arepally, Gowthami M. ;
Padmanabhan, Anand .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (01) :141-152
[3]   Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library [J].
Ashikari-Hada, S ;
Habuchi, H ;
Kariya, Y ;
Itoh, N ;
Reddi, AH ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12346-12354
[4]   OXIDATION OF ALPHA,BETA-UNSATURATED ALDEHYDES [J].
BAL, BS ;
CHILDERS, WE ;
PINNICK, HW .
TETRAHEDRON, 1981, 37 (11) :2091-2096
[5]   A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry [J].
Baleux, Francoise ;
Loureiro-Morais, Latino ;
Hersant, Yael ;
Clayette, Pascal ;
Arenzana-Seisdedos, Fernando ;
Bonnaffe, David ;
Lortat-Jacob, Hugues .
NATURE CHEMICAL BIOLOGY, 2009, 5 (10) :743-748
[6]   Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomes [J].
Baroletti, Steven ;
Piovella, Chiara ;
Fanikos, John ;
Labreche, Matthew ;
Lin, Jay ;
Goldhaber, Samuel Z. .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) :1130-1135
[7]   Advances in the preparation and synthesis of heparin and related products [J].
Baytas, Sultan N. ;
Linhardt, Robert J. .
DRUG DISCOVERY TODAY, 2020, 25 (12) :2095-2109
[8]   Heparan sulphate proteoglycans fine-tune mammalian physiology [J].
Bishop, Joseph R. ;
Schuksz, Manuela ;
Esko, Jeffrey D. .
NATURE, 2007, 446 (7139) :1030-1037
[9]   STUDY OF C-13H COUPLING-CONSTANTS IN HEXOPYRANOSES [J].
BOCK, K ;
PEDERSEN, C .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1974, (03) :293-299
[10]   Atomic description of the immune complex involved in heparin-induced thrombocytopenia [J].
Cai, Zheng ;
Yarovoi, Serge V. ;
Zhu, Zhiqiang ;
Rauova, Lubica ;
Hayes, Vincent ;
Lebedeva, Tatiana ;
Liu, Qun ;
Poncz, Mortimer ;
Arepally, Gowthami ;
Cines, Douglas B. ;
Greene, Mark I. .
NATURE COMMUNICATIONS, 2015, 6